References
- Angastiniotis M, Modell B, Englezos P, Boulyjenkov V. Prevention and control of haemoglobinopathies. Bull World Health Organ 1995; 73(3)375–386
- Cao A, Rosatelli C, Galanello R, Monni G, Olla G, Cossu P, Ristaldi M S. The prevention of thalassemia in Sardinia. Clin Genet 1989; 36(5)277–285
- Lena‐Russo D, Erny N, Serradimigni F, Badens C, Aubinaud M, Merono F, Paolasso C, Mattei J F, Giraud F. Genetic hemoglobin diseases. Prevention at centers for family planning and education of maternal‐child protection in Marseille. Presse Med 1996; 25(4)151–153
- Aluoch J R. Sikkelcelziekte in Nederland, een inventarisatieonderzoek. Ned Tijdschr Geneeskd 1984; 128: 1175–1179
- Rengelink‐van der Lee J H, Schulpen T W, Beemer F A. Incidentie en prevalentie van hemoglobinopathie'n bij kinderen in Nederland. Ned Tijdschr Geneeskd 1995; 139: 1498–1501
- Schulpen T W, van der Lee J H, van der Most van Spijk M W, Beemer F A. Genetic carrier screening for hemoglobinopathies in the Netherlands is not opportune. Ned Tijdschr Geneeskd 1998; 142(18)1019–1022
- Giordano P C, Harteveld C L. Hemoglobinopathieën in Nederland: de rol van de huisarts in dragerschapsdiagnostiek en preventie. Huisarts Wet 1998; 6: 290–295
- Giordano P C, Breuning M H. Van gen naar ziekte; van hemoglobinegenen naar thalassemie en sikkelcelanemie. Ned Tijdschr Geneeskd 2000; 144: 1910–1913
- Modell B, Kuliev A M. A scientific basis for cost‐benefit analysis of genetics services. Trends Genet 1993; 9(2)46–52
- Bain B J, Chapman C. A survey of current United Kingdom practice for antenatal screening for inherited disorders of globin chain synthesis. UK Forum for Haemoglobin Disorders. J Clin Pathol 1998; 51(5)382–389
- Giordano P C, Darlison M, Cario H, Eber S, Lena Russo D, May A, Romão L, Vermylen Ch, Wild B, Wonke B, Modell B. Information as a health care intervention. Adaptation of information and terminology to meet the need of the European Community in the management of hemoglobinopathies. EJHG 2003; 11(suppl 1)P456
- Giordano P C, Harteveld C L, Heister J GAM, Batelaan D, van Delft P, Plug R, Losekoot M, Bernini L F. The molecular spectrum of β‐thalassemia and abnormal hemoglobins in the allochthonous and autochthonous Dutch population. Commun Genet 1998; 1: 243–251
- www.Hbpinfo.com
- Wijk van M AM, Mel M, Muller P A, Silvertand W GJ, Pijnborg L, Kolnar B GM. NHG standaard Anemie. Huisarts & Wet 2003; 46: 3–11
- Elion‐Gerritzen W E, Giordano P C, Haak H L. De standaard ‘Anemie in de eerstelijns verloskundige praktijk’ van de Koninklijke Nederlandse Organisatie van Verloskundigen (KNOV): risico voor het niet onderkennen van ijzergebrek en hemoglobinopathie. Ned Tijdschr Geneeskd 2002; 146: 457–459
- Giordano P C. Stigmatiseren helpt niet. Med Contact 2002; 44: 1607–1610
- www.sikkelcel.nl
- Benkirane Agoumi N, Sebar A. Hemoglobin disorders in Morocco. Arch Pediatr 2003; 10(7)654–655
- Aydinok Y, Oztop S, Nisli G, Kavakli K. Prevalence of β‐thalassaemia trait in 1124 students from Aegean region of Turkey. J Trop Pediatr 1997; 43(3)184–185
- Bircan I, Sisli S, Guven A, Cali S, Yegin O, Ertug H, Guven A G, Akar N. Hemoglobinopathies in the district of Antalya, Turkey. Pediatr Hematol Oncol 1993; 10(3)289–291
- Naamane‐Guessous. Traditional methods still widely used. Plan Parent Chall 1993, 1: 14–16
- Keskin A, Turk T, Polat A, Koyuncu H, Saracoglu B. Premarital screening of β‐thalassemia trait in the province of Denizli, Turkey. Acta Haematol 2000; 104(1)31–33
- Tuzmen S, Tadmouri G O, Ozer A, Baig S M, Ozcelik H, Basaran S, Basak A N. Prenatal diagnosis of β‐thalassaemia and sickle cell anaemia in Turkey. Prenat Diagn 1996; 16(3)252–258